Quoin Pharmaceuticals Ltd. (QNRX)

CIK 1671502 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Quoin Pharmaceuticals Ltd..

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001104659-26-123342
Nov 4, 2026424B50001104659-26-122766
Nov 4, 2026EFFECT9999999995-26-003443
Nov 4, 2026424B50001104659-26-122776
Nov 4, 20268-K0001104659-26-122790
Oct 28, 2026S-30001104659-26-119282
Oct 26, 20264/A0001104659-26-118917
Oct 20, 20268-K0001104659-26-117080
Oct 14, 20268-K0001104659-26-115709
Oct 7, 2026SCHEDULE 13G/A0001778253-26-000004
Oct 2, 2026DEF 14A0001104659-26-113301
Sep 25, 2026424B30001104659-26-111012
Sep 25, 2026EFFECT9999999995-26-003071
Sep 22, 20268-K0001104659-26-109639
Sep 22, 2026PRE 14A0001104659-26-109641
Sep 18, 2026S-30001104659-26-108970
Sep 10, 20268-K0001104659-26-106705
Sep 10, 2026D0001104659-26-106751
Sep 1, 202640001104659-26-104403
Sep 1, 202640001104659-26-104405
Sep 1, 202640001104659-26-104404
Sep 1, 202640001104659-26-104402
Aug 28, 20268-K0001104659-26-102917
Aug 28, 202640001104659-26-103376
Aug 28, 202640001104659-26-103374